Fluid Guided Heart Failure Treatment at the Cleveland Clinic

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Heart Failure
Interventions
DEVICE

Heart Failure Management Intervention

Participants will receive access to their weight and fluid levels on the Cardiac Scale and through the Bodyport Patient Portal. The provider will receive access to the Congestion Index, alerts, and Clinical Dashboard to support the remote management of the participant. The provider will receive a notice when an alert is generated and twice weekly reminders until the Congestion Index returns below an alert threshold. When an alert is generated, providers will attempt to contact the participant and will be encouraged to follow the recommendations contained within the ARG. Providers will also be encouraged to provide feedback and suggest improvements to the ARG throughout the study. Any changes to medical therapy resulting from an alert will be documented in the Bodyport Clinical Dashboard.

Trial Locations (1)

44195

The Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Bodyport Inc.

INDUSTRY

NCT07205120 - Fluid Guided Heart Failure Treatment at the Cleveland Clinic | Biotech Hunter | Biotech Hunter